Document is current
Any future updates will be listed below
-
Authors
Song, Ping
Chen, Sherry X.
Yan, Yan Helen https://orcid.org/0000-0002-1380-4257
Pinto, Alessandro
Cheng, Lauren Y.
Dai, Peng https://orcid.org/0000-0002-4581-3473
Patel, Abhijit A. https://orcid.org/0000-0003-3943-5610
Zhang, David Yu https://orcid.org/0000-0002-0213-7663
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA233364, R01CA203964, R01CA233364)
Cancer Prevention and Research Institute of Texas (RP180147)
- License Information
-
More Information
Article History
Received: 18 September 2019
Accepted: 9 March 2021
First Online: 3 May 2021
Competing interests
: There are patents pending on the BDA (patent number EP3146080B1) and mBDA (patent number WO2019164885A1) methods used in this work. P.S., S.X.C., L.Y.C. and P.D. declare competing interests in the form of consulting for Nuprobe USA. A.A.P. declares a competing interest in the form of consulting for Nuprobe USA as well as consulting for and equity ownership in Binary Genomics. D.Y.Z. declares a competing interest in the form of consulting for and equity ownership in Nuprobe and Torus Biosystems as well as consulting for Avenge Bio.
